Global Biopharmaceutical Company - Bristol Myers Squibb

Latest Milestone for Cell Therapy Portfolio >

Bristol Myers Squibb has received approval from the European Commission for a CAR T cell therapy for adults living with third-line plus relapsed or refractory large B-cell lymphoma (LBCL).

Annual Report >

2021 was a year that illustrated who we are — a company focused on transforming patients’ lives through science. With our dedicated workforce, financial strength, and proven ability to execute, we will continue to advance our pipeline, contribute to our communities, and deliver sustained, long-term growth.

Our R&D Team  >

Learn more about the backgrounds, scientific pursuits and personal interests of members of our research team.

Life & Science Stories

 

A subset of BMS.com, Life & Science Stories is our digital magazine where we share the work our global community of colleagues are doing around the world to help patients and advance scientific innovation.

Survivorship Today

Emmy winner Sterling K. Brown explores cancer survivorship during a global pandemic.

Learn More >

Moving forward.
Together.

Careers

We’re looking for people who want to change lives.  Join us as we transform patients’ lives through science. 

Investors

Learn more about how we strive to produce sustained strong performance and shareholder value.

Looking for Answers?

Quick links to helpful resources.


Clinical Trial Information for Researchers
Clinical trials and research are a critical part of bringing new medicines to patients.

Medical Information for Healthcare Providers
Information and resources to assist with caring for patients.

Help Paying for Your Medicines
If you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help.